Advertisement

International Journal of Clinical Pharmacy

, Volume 40, Issue 1, pp 109–118 | Cite as

Drug-related problems identified during geriatric medication review in the community pharmacy

  • Mounir RhalimiEmail author
  • Alain Rauss
  • Eric Housieaux
Research Article

Abstract

Background In line with the changing role of community pharmacists, we describe here a standardised procedure for detecting DRPs in elderly patients for use in community pharmacies. Objectives The primary aim was to describe the number and type of DRPs identified by community pharmacists in elderly patients. Secondary aims were to determine the number and type of associated pharmacist interventions (PIs) that were transmitted to the prescribers, and to identify risk factors associated with the occurrence of a PI. Setting Community pharmacies. Methods In this prospective, multicentre study, pharmacists received patients aged 65 and over. During a 30-min interview with patients who agreed to participate, patient characteristics were recorded such as age, weight, height, frailty (using the Short Emergency Geriatric Assessment grid), estimated renal function and compliance with treatment assessed by the Girerd scale. Main outcome measure DRPs characteristics. Results A total of 892 patients agreed to participate in 55 pharmacies. Among them 334 DRPs were identified and were associated with 259 PIs. Eighty-nine PIs of 259 were sent to the prescribing physicians; 70 (78%) were implemented by the general practitioner. Factors associated with the occurrence of a DRP are compliance problems [odds ratio (OR) = 1.8, 95% confidence interval (CI) (1.26–2.58)], frailty [OR = 1.3, 95% CI (1.01–1.66)], number of prescribed drugs per day [OR = 1.46, 95% CI (1.02–2.07)] and GFR < 60 mL/min [OR = 1.49, 95% CI (1.01–2.2)]. Conclusion This is the first standardised pharmaceutical assessment dedicated to the elderly carried out by community pharmacists in France. If implemented, it could help to find drug-related problems, identify frail elderly patients and ultimately decrease their exposure to iatrogenic medication errors.

Keywords

Community pharmacy services Drug-related problems France Geriatrics Interprofessional relationships Medication adherence Medication review Pharmacoepidemiology 

Notes

Acknowledgements

The authors wish to thank students and community pharmacists who participated in this study, the representatives of the bodies which supported them, the administrative and medical staffs of the Bertinot Juel Hospital Center in Chaumont-en-Vexin, who actively participate in reflections on clinical pharmacy.

Funding

This study was funded by the Agence Régionale de Santé de Picardie, the Collège Régional des Pharmaciens Maîtres de stage de Picardie, the Association de Pharmacie Hospitalière de l’Oise, la Somme et l’Aisne (APHOSA) and the Bertinot Juel Hospital Center of Chaumont-en-Vexin.

Conflicts of interest

Authors declare that they have no conflict of interest.

References

  1. 1.
    Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 2000.Google Scholar
  2. 2.
    Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–9.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205–11.CrossRefPubMedGoogle Scholar
  4. 4.
    Morice E, Gabriel-Bordenave C, Auclair V, Juste M, Roberge C. Évaluation de la pratique d’analyse d’ordonnance dans les hôpitaux français [Evaluation of prescription checking practices by French hospital Pharmacists]. Le Pharmacien Hospitalier et Clinicien. 2011;46(3):293–5.CrossRefGoogle Scholar
  5. 5.
    Martin SF, Van Mil JW, Da Costa FA. The organizational framework of community pharmacies in Europe. Int J Clin Pharm. 2015;37(5):896–905.CrossRefGoogle Scholar
  6. 6.
    Harris IM, Phillips B, Boyce E, Griesbach S, Hope C, Sanoski C, et al. Clinical pharmacy should adopt a consistent process of direct patient care. Pharmacotherapy. 2014;34(8):e133–48.CrossRefPubMedGoogle Scholar
  7. 7.
    Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. Adverse drug events prevention group. The costs of adverse drug events in hospitalized patients. JAMA. 1997;277(4):307–11.CrossRefPubMedGoogle Scholar
  8. 8.
    Gallagher J, Byrne S, Woods N, Lynch D, McCarthy S. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital. BMC Health Serv Res. 2014;14:177.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Dooley MJ, Allen KM, Doecke CJ, Galbraith KJ, Taylor GR, Bright J, et al. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol. 2004;57(4):513–21.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tinetti M, Fried T, Boyd C. Designing health care for the most common chronic condition: multimorbidity. JAMA. 2012;307(23):2493–4.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Christensen M, Lundh A. Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2016;(2):CD008986.  https://doi.org/10.1002/14651858.CD008986.pub3.
  12. 12.
    Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55:809–17.CrossRefPubMedGoogle Scholar
  13. 13.
    Chan DC, Chen JH, Kuo HK, We CJ, Lu IS, Chiu LS, et al. Drug-related problems (DRPs) identified from geriatric medication safety review clinics. Arch Gerontol Geriatr. 2012;54(1):168–74.CrossRefPubMedGoogle Scholar
  14. 14.
    Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics ans pharmacodynamics: basic principles and pratical applications. Br J Clin Pharmacol. 2004;57:6–14.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Charpiat B, Conort O, Juste M, Rose FX, Roubille R, Bedouch P, et al. The French Society of clinical pharmacy ACT-IP project: ten years onward, results and prospects. Le Pharmacien Hospitalier et Clinicien. 2015;50:15–24.CrossRefGoogle Scholar
  16. 16.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (ScreeningTool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Oubaya N, Mahmoudi R, Jolly D, Zulfiqar AA, Quignard E, Cunin C, et al. Screening for frailty in elderly subjects living at home: validation of the modified Short Emergency Geriatric assessment (SEGAm) instrument. J Nutr Health Aging. 2014;18(8):757–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Evaluation de l’observance du traitement anti-hypertenseur par un questionnaire: mise au point et utilisation dans un service specialisé [Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic]. Presse Med. 2001;30:1044–8.PubMedGoogle Scholar
  19. 19.
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.CrossRefPubMedGoogle Scholar
  20. 20.
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Int Med. 1999;130(6):461–70.CrossRefPubMedGoogle Scholar
  21. 21.
    Allenet B, Bedouch P, Rose FX, Escofier L, Roubille R, Juste M, et al. Validation of an instrument for the documentation of clinical pharmacists interventions. Pharm World Sci. 2006;28:181–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Helou R. Should we continue to use the Cockcroft–Gault formula? Nephron Clin Pract. 2010;116:c172–85.CrossRefPubMedGoogle Scholar
  23. 23.
    Bell JS, Blacker N, Leblanc VT, Alderman PC, Phillips A, Rowett D, et al. Prescribing for older people with chronic renal impairment. Aust Fam Phys. 2013;42(1–2):24–8.Google Scholar
  24. 24.
    Basger BJ, Moles RJ, Chen TF. Application of drug-related problem (DRP) classification systems: a review of the literature. Eur J Clin Pharmacol. 2014;70(7):799–815.CrossRefPubMedGoogle Scholar
  25. 25.
    Krähenbühl JM, Kremer B, Guignard B, Bugnon O. Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharm World Sci. 2008;30(6):777–86.CrossRefPubMedGoogle Scholar
  26. 26.
    Nicolas A, Eickhoff C, Griese N, Schulz M. Drug-related problems in prescribed medicines in Germany at the time of dispensing. Int J Clin Pharm. 2013;35(3):476–82.CrossRefPubMedGoogle Scholar
  27. 27.
    Bedouch P, Sylvoz N, Charpiat B, Juste M, Roubille R, Rose FX, et al. Trends in pharmacists’ medication order review in French hospitals from 2006 to 2009: analysis of pharmacists’ interventions from the Act-IP© website observatory. J Clin Pharm Ther. 2015;40(1):32–40.CrossRefPubMedGoogle Scholar
  28. 28.
    Bardet JD, Vo T-H, Bedouch P, Allenet B. Physicians and community pharmacists collaboration in primary care: a review of specific models. Res Soc Adm Pharm. 2015;11(5):602–22.CrossRefGoogle Scholar
  29. 29.
    Tan E, Stewart K, Elliott R. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Soc Adm Pharm. 2014;10(4):608–22.CrossRefGoogle Scholar
  30. 30.
    Hirsch JD, Steers N, Adler DS. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36(9):1244–54.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Taylor DG, Garfield S, Hawkins J, Newbould J, Rennie T. Greater expectations. Pharmacy based health care: the future for Europe? Policy Paper. 2007;5:1–19.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Centre Hospitalier Bertinot Juël, Service PharmacieChaumont en VexinFrance
  2. 2.INSERM U1088, Université de Picardie Jules VerneAmiensFrance
  3. 3.ARCOSALimeil-Brévannes, Val de MarneFrance
  4. 4.Faculté de PharmacieAmiens Cedex 1France

Personalised recommendations